Delivery Order SPE2DR25D2206-SPE2DR26F9DC8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,212.33 to AmerisourceBergen Drug Corp for Nitazoxanide 500 mg tablets in quantities of six, with an ultimate completion date of August 15, 2025. This firm fixed-price, non-set-aside contract was awarded on August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Nitazoxanide is an antiprotozoal and antiviral medication commonly used to treat parasitic and infectious...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Nitazoxanide 500 mg tablets in quantities of six units. This firm fixed-price delivery order, valued at $3,512.48, represents a non-competitive set-aside and is scheduled for completion by November 6, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,212.70 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for Nitazoxanide 500 mg tablets in quantities of six. This competitively awarded, non-set-aside contract is scheduled for ultimate completion on December 11, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $12,027.91 to AmerisourceBergen Drug Corp for the supply of Nitazoxanide 500 mg tablets in quantities of six units. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of October 27, 2025. The award was made on October 24, 2025, with performance occurring at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $5,022.83 to AmerisourceBergen Drug Corp for the supply of Nitazoxanide 500 mg tablets (quantity 6 units). This competitive, non-set-aside award was executed on November 3, 2025, with an ultimate completion date of November 4, 2025, under a firm fixed-price contract type. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Nitazoxanide 500 mg tablets in packages of six, with a ceiling value of $1,685.10 and a firm fixed price structure. This non-set-aside competitive award is scheduled for completion by November 28, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $12,378.20 to AmerisourceBergen Drug Corp for the supply of Nitazoxanide 500 mg tablets (quantity of six units) on December 9, 2025, with completion scheduled for December 10, 2025. The award is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive selection. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a $3,477.04 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Nitazoxanide 500 mg tablets in quantities of six. The contract is firm fixed price with no set-aside designation and is scheduled for completion by August 14, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is registered in the System for Award...
- This is a $30,921.83 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a large pharmaceutical distributor. The contract is for the supply of 4,565,440 units of the pharmaceutical product Nitazoxanide 500 mg tablets. The ultimate completion date is August 14, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,699.22 firm-fixed-price contract is for the supply of 4565295255 - Nitazoxanide 500 mg tablets. The contract has an ultimate completion date of July 31, 2024 and was awarded on July 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which provides a...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9DC8Delivery Order
The Defense Logistics Agency awarded a $32,047.25 delivery order to AmerisourceBergen Drug Corp for Nitazoxanide 500 mg tablets (6-count packages) on November 24, 2025, with completion scheduled for November 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Nitazoxanide is an antiparasitic medication commonly used to treat various parasitic and gastrointestinal infections, representing part of the Defense Logistics Agency's critical pharmaceutical procurement for military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a leading pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies comprehensive pharmaceutical products and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. The parent IDC serves as a flexible contracting vehicle enabling the company to deliver a vast range of pharmaceutical products, vaccines, and medical supplies globally to support Defense Health Agency customers and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.0k | 11/23/25 |